Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Update

13 May 2021 07:00

RNS Number : 4561Y
Alumasc Group PLC
13 May 2021
 

13 May 2021

The Alumasc Group plc

("Alumasc")

Trading Update - Strong last four months' performance

 

Alumasc, the premium building products, systems, and solutions Group, today provides a trading update for the ten months ended 30 April 2021.

 

Our absolute focus continues to be the safety of our employees, customers, suppliers, and sub-contractors as we continue to manage the impact of the Covid-19 pandemic in accordance with latest UK Government guidelines.

 

Following a record first half year performance that saw double digit revenue growth and also a double digit return on sales, it is pleasing to report that this momentum has continued into Alumasc's last four months.

 

All of Alumasc's divisions have contributed to this strong performance in the period. The businesses have been successful in winning market share and have been further supported by encouraging export sales. Additionally, the restructuring during FY 2020, which delivered £2.4m in annual cost savings, has supported improved margins. Levolux continues to benefit from its turnaround plan, with a return to consistent profitability and a substantially improved performance this financial year.

 

 

Conditions in our markets, particularly in the new build housing and RMI sectors, have continued to be strong into the second half year, underpinned by the government's continuation of its stamp duty holiday and first-time buyer support, and we would anticipate demand remaining strong through the remainder of the year to 30 June 2021. Our businesses have seen increasing raw material and shipping cost inflation in recent months, but these are being managed with customers and suppliers to maintain margins over the medium term. As a consequence of the continued strong momentum, the Board now expects that Alumasc's results for the year will be ahead of its previous expectations.

 

Paul Hooper, CEO, commented: 'The great potential for the Group is starting to be realised with a strong continuation of the good performance seen in H1.

 

Together with the benefit of the structural efficiency improvements made by the Group in recent years and the continuing progress on the Levolux turnaround plan, the Group is well positioned to benefit from the significant opportunities within our markets, both short and longer term.'

 

This announcement contains inside information for the purposes of Market Abuse Regulation (Regulation (EU) No. 596/2014). The person responsible for making this announcement on behalf of the Company is Helen Ashton, Group Company Secretary.

 

 

For further information please contact:

 

The Alumasc Group plc

Paul Hooper, CEO + 44 (0) 1536 383844

Simon Dray, Group Finance Director + 44 (0) 1536 383844

Helen Ashton, Group Company Secretary + 44 (0) 1536 383812

 

Peel Hunt (Broker)

Mike Bell + 44 (0) 207 418 8831

Ed Allsopp

 

finnCap (NOMAD)

Julian Blunt + 44 (0) 207 220 0561

Camarco

Ginny Pulbrook + 44 (0) 203 757 4992

Tom Huddart + 44 (0) 203 757 4991

Email: alumasc@camarco.co.uk

Notes to Editors:

Alumasc is a UK-based supplier of premium building products, systems and solutions. Almost 80% of group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Building Envelope; Water Management; and Housebuilding Products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKBBBCBKDDPD
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.